investor.worldsourcesecurities.com
/APFront
Service des valeurs mobilières. Log In/Ouverture de session. Please fill out this field. Veuillez remplir ce champ. ce champ. Please fill out this field. Veuillez remplir ce champ. ce champ. Forgot your user ID. Vous avez oublié votre ID utilisateur. Ou votre mot de passe. 2001 2015 IBM Corporation, Trademark. 2001 2015 IBM Corporation, marques de commerce. Forgot your login info? Vous avez oublié vos données de connexion? Back to Login/Retourner à l’ouverture de session.
investor.wpglimcher.com
Investor Relations| WP GLIMCHER
Delayed approx. 15 minutes. 160; 69.15. 160; 14.68. 160; 8.15. 160; 0.03. To find out more about WP GLIMCHER, click here. To read who we are. 160; 0.03. As of 08/14/15 4:04 pm ET. Minimum 20 minute delay. WP Glimcher Reports Second Quarter 2015 Results. WP Glimcher Announces Timing of Second Quarter 2015 Conference Call. WP Glimcher Completes 5-Year, $500 Million Term Loan; Company Fully Repays Remainder of Bridge Loan. WP Glimcher Completes Formation of Joint Venture with O’Connor Capital Partners for F...
investor.wyndhamworldwide.com
Wyndham Worldwide Investor Relations
Wyndham Pigeon Forge Tennessee. 17% - 21% EPS CAGR. Wyndham Grand Chicago, Illinois. World's largest hotel company. World’s largest vacation exchange and professionally managed vacation rentals company. World's largest vacation ownership company. One of the world's largest hospitality companies, Wyndham Worldwide (NYSE: WYN) provides a wide range of hospitality products and services through its global portfolio of world-renowned brands. World's largest hotel company. As the world's largest developer and ...
investor.xenon-pharma.com
Investor Overview | Xenon Pharma
From families to genes, from genes to drugs. Xenon Pharmaceuticals Inc at Canaccord Genuity 35th Annual Growth Conference. August 13, 2015. 160;at 10:30 am ET. Xenon Pharmaceuticals Inc at Canaccord Genuity 35th Annual Growth Conference. Thursday, August 13, 2015 . 10:30 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 1.10. Data as of August 17, 2015 4:00 pm ET. Minimum 20 minute delay. August 10, 2015. There are currently no events scheduled.
investor.xenoport.com
XenoPort, Inc. > Corporate Profile
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. XenoPort is currently commercializing Horizant. Gabapentin enacarbil) Extended-Release Tablets, its first approved product in the United States, and developing a novel fumaric acid ester product candidate, XP23829, as a potential treatment for relapsing-remitting multiple sclerosis and/or psoriasis. U=http:/ ...
investor.xilinx.com
Xilinx.com : Investor Relations
We have detected your current browser version is not the latest one. Xilinx.com uses the latest web technologies to bring you the best online experience possible. Please upgrade to a Xilinx.com supported browser: Chrome. Broadcast and Pro A/V. Showcase of Products Enabled by Xilinx Technology. FPGAs and 3D ICs. Showcase of Products Enabled by Xilinx Technology. Shaping the Future of Next Generation Systems. Vivado Design Suite - HLx Editions. Boards, Kits, and Modules. Xilinx GO Mobile App. Jan 24, 2018.
investor.xlgroup.com
Events | Investor Relations | XL
Separately, XL and Catlin were two strong, innovative companies. Together, we're even stronger. Find out more about XL Catlin. Please do not show me this message again. Catlin Acquisition US Tax Information. Mergers and Acquisition Announcement. XL Group plc Announces Second Quarter 2015 Results. Q2 2015 XL Group plc Earnings Conference Call. XL Group plc Announces $1 Billion Share Buyback Program and Increase in Ordinary Share Dividends from $0.16 to $0.20 per Share. 160;at 10:00 am ET. WORK AT XL GROUP.
investor.xt.pl
xt.pl - This website is for sale! - xt Resources and Information.
The owner of xt.pl. Is offering it for sale for an asking price of 10000 EUR! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
investor.xtantmedical.com
XTANT Medical | Investors Overview | Investors
Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and.
SOCIAL ENGAGEMENT